OncGenius-Leukemia

Determining Risk of Relapse After Bone Marrow Transplant Among Patients With AML Posted: 03/20/2023 | By: Chase Doyle Researchers have found that screening for residual disease prior to a bone marrow transplant using a blood test may help physicians identify which adult patients in remission from acute myeloid…

Read the full article here

Related Articles